about
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritisPrediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.Prediction of disease severity in patients with early rheumatoid arthritis by gene expression profiling.Radiographic estimation in seropositive and seronegative rheumatoid arthritisCombination treatment strategies in early rheumatoid arthritis.Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trialPredictive factors of radiographic progression in ankylosing spondylitis.Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.Pharmacological management of transient synovitis.Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.Novel multiplex technology for diagnostic characterization of rheumatoid arthritis.Value of digital X-ray radiogrammetry in the assessment of inflammatory bone loss in rheumatoid arthritis.Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review.Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity.
P2860
Q33355906-E1584169-A80A-4A56-868E-E4E2CD1468A5Q33747444-28618241-8152-4A58-9F80-1FA6207E1885Q34177096-144C68CB-A584-46A9-8892-D7EFC3D3B14EQ35184666-844BA5C0-BDCC-40DA-899D-8DC635886287Q35556077-84FB793D-D227-41C6-8207-D29995396CA8Q35562353-B739E96F-AC33-4D52-90F5-0AA261D9E0E4Q35626275-82D447A2-AA11-4216-979F-AFEEBC0336D3Q35814091-387F0CCC-E9F2-4E3B-9C2F-4D58B7EA1A2FQ36183852-478EC8E3-9CDC-4EDC-BA7C-B9C50BCDAFCEQ36251297-77518AE9-D267-4EB4-963B-F89992B72885Q36349593-B7FD839B-517B-45C0-B54B-968FD0677405Q37350853-D2EBCB66-BCCF-4EDD-ACA5-12DB52B2BA63Q38077142-D17452A6-0825-4669-AD1A-105A55812695Q38185644-C17628A5-BE1C-42A2-BF07-EB114BECEE4EQ39186261-5A3D63CE-F385-4314-89D0-6685377BE389Q39982542-89123EB2-AF81-46BC-A0DF-2958A12A17E6Q39998140-C8738499-E4D0-4767-B827-3B875135A01EQ40564193-3D01D3C9-C4BD-4972-BAC5-7C55C561853BQ41931049-D6252EA2-F0F9-481B-9EAF-02EA61A37BF1Q41948703-9310A579-3E7A-4186-8FD6-04829B3C943CQ42199862-B518F710-F1D8-4DE0-B4BE-CC017896354EQ45055039-58B59645-2DA0-4BF0-8A74-A1207627F17DQ47567325-59C4C70D-30A0-407F-9FB2-4B7FD47C997BQ47831537-F2FB9BD5-2F78-4DCB-8D1A-D04E4A034287
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
How to predict prognosis in early rheumatoid arthritis.
@ast
How to predict prognosis in early rheumatoid arthritis.
@en
type
label
How to predict prognosis in early rheumatoid arthritis.
@ast
How to predict prognosis in early rheumatoid arthritis.
@en
prefLabel
How to predict prognosis in early rheumatoid arthritis.
@ast
How to predict prognosis in early rheumatoid arthritis.
@en
P1476
How to predict prognosis in early rheumatoid arthritis.
@en
P304
P356
10.1016/J.BERH.2004.08.008
P577
2005-02-01T00:00:00Z